Tech Company Financing Transactions

Ocular Therapeutix Funding Round

Ocular Therapeutix closed a $37.5 million venture capital round on 3/19/2019. Investors included private investors.

Transaction Overview

Company Name
Announced On
3/19/2019
Transaction Type
Debt
Amount
$37,500,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 1 investor participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.

Company Information

Company Status
Publicly-held
Industry
Medical Devices & Instruments
Mailing Address
24 Crosby Dr.
Bedford, MA 01730
USA
Email Address
Overview
Ocular Therapeutix, Inc. (NASDAQ: OCUL) is a company focused on the development and commercialization of ophthalmic therapeutic products using its proprietary hydrogel technology to address unmet or underserved needs in ophthalmology and ophthalmic surgery.
Profile
Ocular Therapeutix LinkedIn Company Profile
Social Media
Ocular Therapeutix Company Twitter Account
Company News
Ocular Therapeutix News
Facebook
Ocular Therapeutix on Facebook
YouTube
Ocular Therapeutix on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Antony Mattessich
  Antony Mattessich LinkedIn Profile  Antony Mattessich Twitter Account  Antony Mattessich News  Antony Mattessich on Facebook
Chief Financial Officer
Donald Notman
  Donald Notman LinkedIn Profile  Donald Notman Twitter Account  Donald Notman News  Donald Notman on Facebook
Chief Medical Officer
Michael Goldstein
  Michael Goldstein LinkedIn Profile  Michael Goldstein Twitter Account  Michael Goldstein News  Michael Goldstein on Facebook
Chief Scientific Officer
Peter Jarrett
  Peter Jarrett LinkedIn Profile  Peter Jarrett Twitter Account  Peter Jarrett News  Peter Jarrett on Facebook
VP - General Counsel
Jonathan Sparks
  Jonathan Sparks LinkedIn Profile  Jonathan Sparks Twitter Account  Jonathan Sparks News  Jonathan Sparks on Facebook
VP - Marketing
Scott Corning
  Scott Corning LinkedIn Profile  Scott Corning Twitter Account  Scott Corning News  Scott Corning on Facebook
VP - Product Management
Art Driscoll
  Art Driscoll LinkedIn Profile  Art Driscoll Twitter Account  Art Driscoll News  Art Driscoll on Facebook


 

 

Browse more venture capital transactions:

Prev: 3/19/2019: Imara Inc. venture capital transaction
Next: 3/19/2019: Danimer Scientific venture capital transaction

 

Share this article

 


About Our VC Transactions Data

We report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary